• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

外源性胰岛素在 2 型糖尿病患者中的安全性：令人担忧的理由。

The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern.

机构信息

School of Medicine, Cardiff University, Cardiff, UK.

出版信息

Diabetes Obes Metab. 2012 Jan;14(1):1-4. doi: 10.1111/j.1463-1326.2011.01469.x. Epub 2011 Nov 21.

DOI:10.1111/j.1463-1326.2011.01469.x
PMID:21736688
Abstract

There is no doubt about the value of exogenous insulin for people with type 1 diabetes. The purpose of this commentary is to discuss emerging evidence that this may not be the case for the majority of people with type 2 diabetes.

摘要

对于 1 型糖尿病患者来说，外源性胰岛素的价值毋庸置疑。本文的目的是讨论新出现的证据，即对于大多数 2 型糖尿病患者来说，情况可能并非如此。

相似文献

1
The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern.外源性胰岛素在 2 型糖尿病患者中的安全性：令人担忧的理由。
Diabetes Obes Metab. 2012 Jan;14(1):1-4. doi: 10.1111/j.1463-1326.2011.01469.x. Epub 2011 Nov 21.
2
[Application and practice of intensive insulin therapy].[强化胰岛素治疗的应用与实践]
Nihon Rinsho. 2002 Sep;60 Suppl 9:297-303.
3
[Multiple insulin injections therapy as an intensive insulin therapy].[多次胰岛素注射疗法作为一种强化胰岛素治疗]
Nihon Rinsho. 1997 Nov;55 Suppl:249-54.
4
Exorcising the specter of nighttime hypoglycemia.消除夜间低血糖的隐患。
Diabetes Self Manag. 2012 Jan-Feb;29(1):16, 18-20.
5
[Syndrome of chronic overdose of insulin and hypoglycemic sulfanilamide drugs].[胰岛素和降糖磺胺类药物慢性过量综合征]
Klin Med (Mosk). 1989 Apr;67(4):99-101.
6
Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes.胰岛素和口服降糖药不应联合用于2型糖尿病的治疗。
Arch Intern Med. 2003;163(15):1783-5; discussion 1785. doi: 10.1001/archinte.163.15.1783.
7
Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine.使用中效胰岛素或甘精胰岛素评估 2 型糖尿病患者低血糖风险的个体患者数据荟萃分析。
Diabetes Obes Metab. 2010 Sep;12(9):772-9. doi: 10.1111/j.1463-1326.2010.01232.x.
8
Poor glycaemic control caused by insulin induced lipohypertrophy.胰岛素诱导的脂肪增生导致血糖控制不佳。
BMJ. 2003 Aug 16;327(7411):383-4. doi: 10.1136/bmj.327.7411.383.
9
[Hypoglycemia--a dreaded complication of diabetes].低血糖——糖尿病可怕的并发症
Tidsskr Nor Laegeforen. 2000 Aug 30;120(20):2441-4.
10
[Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].[严重低血糖与代谢控制及患者知识的相关性发病率]
Med Klin (Munich). 1995 Oct 15;90(10):557-61.

引用本文的文献

1
Diabetes and Cancer: Risk, Challenges, Management and Outcomes.糖尿病与癌症：风险、挑战、管理及预后
Cancers (Basel). 2021 Nov 16;13(22):5735. doi: 10.3390/cancers13225735.
2
The association of intravenous insulin and glucose infusion with intensive care unit and hospital mortality: a retrospective study.静脉输注胰岛素和葡萄糖与重症监护病房及医院死亡率的关联：一项回顾性研究。
Ann Intensive Care. 2019 Feb 11;9(1):29. doi: 10.1186/s13613-019-0507-x.
3
Impact of diabetes and early revascularization on the need for late and repeat procedures.
糖尿病和早期血运重建对晚期和再次介入治疗需求的影响。
Cardiovasc Diabetol. 2018 Feb 5;17(1):25. doi: 10.1186/s12933-018-0669-0.
4
Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.经皮冠状动脉血运重建术后的死亡率：既往心血管危险因素控制与糖尿病患者预后改善
Catheter Cardiovasc Interv. 2017 Jun 1;89(7):1195-1204. doi: 10.1002/ccd.26882. Epub 2016 Dec 28.
5
Glucagon-like Peptide 1 Drugs as Second-line Therapy for Type 2 Diabetes.胰高血糖素样肽-1药物作为2型糖尿病的二线治疗药物
JAMA Intern Med. 2016 Oct 1;176(10):1-3. doi: 10.1001/jamainternmed.2016.1523.
6
Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials.胰岛素治疗2型糖尿病的疗效与安全性：随机对照试验的荟萃分析
BMC Endocr Disord. 2016 Jul 8;16(1):39. doi: 10.1186/s12902-016-0120-z.
7
Outcome studies and safety as guide for decision making in treating patients with type 2 diabetes.以结局研究和安全性为指导，为 2 型糖尿病患者的治疗决策提供依据。
Rev Endocr Metab Disord. 2016 Mar;17(1):117-27. doi: 10.1007/s11154-016-9351-6.
8
Role of Emerging Insulin Technologies in the Initiation and Intensification of Insulin Therapy for Diabetes in Primary Care.新兴胰岛素技术在基层医疗中糖尿病胰岛素治疗起始及强化治疗中的作用
Clin Diabetes. 2016 Jan;34(1):34-43. doi: 10.2337/diaclin.34.1.34.
9
The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema.糖尿病新分类系统时机已到：以β细胞为中心的分类模式的基本原理及影响
Diabetes Care. 2016 Feb;39(2):179-86. doi: 10.2337/dc15-1585.
10
Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: a systematic review.2型糖尿病患者使用不同胰岛素治疗方案时的心血管发病率和死亡率比较：一项系统评价
BMJ Open. 2015 Mar 11;5(3):e006341. doi: 10.1136/bmjopen-2014-006341.